The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Douglas Earl Martin since 2025.
This trader's CIK number is 1362155.
At the time of last reporting, Douglas Earl Martin was the SVP, General Counsel of Allogene Therapeutics, Inc.. (stock ticker symbol ALLO).
Also see all insider trading activities at Allogene Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2026 | ALLO | 0 | $0 | 22,900 | $40,304 | 0 | $0 |
| 2025 | ALLO | 0 | $0 | 6,404 | $10,950 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-02-02 | ALLO | Sale | 22,900 | 1.76 | 40,304 |
| 2025-02-03 | ALLO | Sale | 6,404 | 1.71 | 10,950 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Douglas Earl Martin (SVP, General Counsel of Allogene Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.